Table 1.
Demographic baseline of CRCLM patients.
| Variable | Value | |||
|---|---|---|---|---|
| − Metformin | + Metformin | |||
| − Other Antidiabetics | + Other Antidiabetics | |||
| 1 | Sex | |||
| Male | 59 | 6 | 7 | |
| Female | 29 | 4 | 3 | |
| 2 | Age | |||
| <50 years | 4 | 0 | 0 | |
| 50–70 years | 45 | 4 | 5 | |
| >70 years | 39 | 6 | 5 | |
| 3 | Body mass index category (BMI) | |||
| Underweight (BMI ≤ 18.5) | 0 | 0 | 0 | |
| Normal (BMI = 18.5–24.9) | 30 | 2 | 3 | |
| Overweight (BMI = 25.0–29.9) | 36 | 4 | 5 | |
| Obese (BMI ≥ 30.0) | 21 | 3 | 2 | |
| Insufficient data | 1 | 1 | 0 | |
| 4 |
Histopathological growth pattern (HGP)
(50% predominant HGP cut-off) |
|||
| Replacement HGP (RHGP) | 42 | 2 | 4 | |
| Desmoplastic HGP (DHGP) | 27 | 6 | 4 | |
| Mixed | 19 | 2 | 2 | |
| 5 | Neoadjuvant before liver resection | |||
| Yes | 74 | 5 | 7 | |
| No | 12 | 5 | 3 | |
| Insufficient data | 2 | 0 | 0 | |